Grants & Projects per year
Fingerprint
Dive into the research topics where Fengshuo Lan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GO44900: A Phase Ib Study Evaluating Safety Efficacy Pharmacokinetics & Pharmacodynamics of Glofitamab in Comination with Gemcitabine plus Oxaliplatin in Patients from Racial-Ethnic Minorities with Relapsed or Refractory Diffuse Cell Lympho
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
05/1/26 → 01/28/27
Project: Research
-
Ntrust-2: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy in Subjects with Immune-Mediated Diseases
Schuster, M. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI) & Liu, S. (CoPI)
05/5/25 → 02/3/27
Project: Research
-
GO43878: A Phase III, Open-label, Multicenter, Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
06/26/26 → 08/29/26
Project: Research
-
Ntrust-1: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with Autoimmune Disease
Yao, Q. P. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI), Liu, S. (CoPI) & Schuster, M. (CoPI)
05/16/25 → 08/19/26
Project: Research
-
ICT-8 Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Patients Unfit for Standard Chemotherapy
Gabig, T. (CoPI), Lan, F. (CoPI), Schuster, M. (CoPI), Salman, H. (PI) & Kiner-Strachan, B. (CoPI)
10/27/17 → 08/2/19
Project: Research
Research output
- 14 Article
-
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial
Masarova, L., Reeves, B. N., El Chaer, F., Foltz, L., Tashi, T., Abu-Zeinah, G., Lucas, J., Halpern, A. B., Maze, D., Qin, A., Safah, H., Lan, F., O'Connell, C. L., Goel, S., Rein, L., Fang, B., How, J., Babu, S., Li, Z. & Cerquozzi, S. & 11 others, , 2025, In: Frontiers in Medicine. 12, 1548590.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
Chen, K. H., Wada, M., Pinz, K. G., Liu, H., Lin, K. W., Jares, A., Firor, A. E., Shuai, X., Salman, H., Golightly, M., Lan, F., Senzel, L., Leung, E. L., Jiang, X. & Ma, Y., Oct 1 2017, In: Leukemia. 31, 10, p. 2151-2160 10 p.Research output: Contribution to journal › Article › peer-review
Open Access173 Scopus citations -
Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
Pinz, K. G., Yakaboski, E., Jares, A., Liu, H., Firor, A. E., Chen, K. H., Wada, M., Salman, H., Tse, W., Hagag, N., Lan, F., Leung, E. L. H., Jiang, X. & Ma, Y., 2017, In: Oncotarget. 8, 68, p. 112783-112796 14 p.Research output: Contribution to journal › Article › peer-review
Open Access93 Scopus citations -
Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
Chen, K. H., Wada, M., Firor, A. E., Pinz, K. G., Jares, A., Liu, H., Salman, H., Golightly, M., Lan, F., Jiang, X. & Ma, Y., 2016, In: Oncotarget. 7, 35, p. 56219-56232 14 p.Research output: Contribution to journal › Article › peer-review
Open Access112 Scopus citations -
Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells
Pinz, K., Liu, H., Golightly, M., Jares, A., Lan, F., Zieve, G. W., Hagag, N., Schuster, M., Firor, A. E., Jiang, X. & Ma, Y., Mar 1 2016, In: Leukemia. 30, 3, p. 701-707 7 p.Research output: Contribution to journal › Article › peer-review
101 Scopus citations